Mireille Sanders
Fortuna: 1 M $ al 31/07/2026
Fortuna: 1 M $ al 31/07/2026
Mireille Sanders is currently the Chief Operations Officer at Pharming Group NV.
Previously, she worked at Janssen Pharmaceuticals, Inc. as the Head-Clinical Supply Chain Strategic from 2016 to 2019.
Ms. Sanders is a graduate of Technische Universiteit Eindhoven.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARMING GROUP NV 0,17 % | 31/03/2026 | 1.232.350 ( 0,17 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMING GROUP N.V. | Director de Operaciones | 15/12/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Technische Universiteit Eindhoven
Technische Universiteit Eindhoven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.